<SEC-DOCUMENT>0000950170-25-043488-index.html : 20250324
<SEC-HEADER>0000950170-25-043488.hdr.sgml : 20250324
<ACCEPTANCE-DATETIME>20250324070458
ACCESSION NUMBER:		0000950170-25-043488
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20250324
DATE AS OF CHANGE:		20250324
EFFECTIVENESS DATE:		20250324

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lexeo Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001907108
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				854012572
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-286040
		FILM NUMBER:		25762200

	BUSINESS ADDRESS:	
		STREET 1:		345 PARK AVENUE SOUTH
		STREET 2:		FLOOR 6
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010
		BUSINESS PHONE:		(212) 547-9879

	MAIL ADDRESS:	
		STREET 1:		345 PARK AVENUE SOUTH
		STREET 2:		FLOOR 6
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>lxeo_s-8_evergreen_2025.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: lxeo_s-8_evergreen_2025.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>lxeo-ex5_1.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: lxeo-ex5_1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>lxeo-ex23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 3 - file: lxeo-ex23_1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>lxeo-exfiling_fees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 4 - file: lxeo-exfiling_fees.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img155268912_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: img155268912_0.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>img238985936_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: img238985936_0.jpg

</DOCUMENT>
</SEC-DOCUMENT>